BridgeBio Pharma, Inc. (BBIO)

NASDAQ

$65.39

$+0.01

(+0.02%)

Regular Market

BridgeBio Pharma, Inc. (BBIO) Live Price Chart

Last updated: ⁦2026-10-12 13:43:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

BridgeBio Pharma, Inc. (BBIO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $65.39, with a market capitalisation of $12.78B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $52.75 to $93.42. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$12.78B
Open	$65.37
Day's High	$93.42
Day's Low	$4.98
Previous Close	$65.35
Volume	94.74K
Average Volume	2.40M
P/E Ratio	--
52-Week High	$93.42
52-Week Low	$52.75
Dividend Yield	--
Earnings Date	--

BridgeBio Pharma, Inc. (BBIO) Stock Price Today

BridgeBio Pharma, Inc. (BBIO) is currently trading at $65.39 as of 2026-10-12 13:41:00, up 0.06% ($0.04) from the previous close of $65.35

During today's regular trading session, BBIO has traded between $4.98 and $93.42, with a trading volume of 94.74K shares. The current price is near the upper end of today's range.

BridgeBio Pharma, Inc. (BBIO) 7-Day Stock Price Change

Over the past seven days, BridgeBio Pharma, Inc. (BBIO) moved from $66.91 to $65.39, representing a decline of 2.27% ($1.52).

The stock traded between $63.70 and $68.68 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 2.76 million shares, down versus the previous seven-day period, indicating lower trading activity.

BBIO 52-Week Price Position

Position in Range: 31.1%

52W Low$52.75

52W High$93.42

BBIO is currently trading at $65.39, placing it 31.1% of the way from its 52-week low of $52.75 to its 52-week high of $93.42. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is BridgeBio Pharma, Inc. (BBIO)?

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. Its key drug is Attruby (acoramidis), an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

BridgeBio Pharma, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	839
Exchange	NASDAQ
Company Website	https://www.bridgebio.com

How to Buy BridgeBio Pharma, Inc. (BBIO) Stock on MEXC

Eligible investors can buy real shares of BridgeBio Pharma, Inc. (BBIO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for BBIO and Place Your Order

Open the RealStocks trading page and search for BBIO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is BridgeBio Pharma, Inc. (BBIO) stock price today?

BridgeBio Pharma, Inc. (BBIO) is currently trading at $ 65.39, up 0.06% ($0.04) from the previous close of $ 65.35. Intraday prices update in real time during regular trading hours.

2.Is BBIO stock going up or down today?

As of 2026-10-12 13:41:00, BBIO is trading at $ 65.39, up 0.06% ($0.04) from its previous close of $ 65.35. The stock has traded between $ 4.98 and $ 93.42 during today’s regular session. Past price movements do not guarantee future results.

3.What is BBIO pre-market price?

As of 2026-10-12 13:41:00, BBIO is trading at $ 65.56 in pre-market trading, up 0.32% ($0.21) from the previous close of $ 65.35. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is BBIO after-hours price?

As of 2026-10-12 13:41:00, BBIO is trading at $ 65.35 in after-hours trading, unchanged from the regular-session close of $ 65.35. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is BBIO stock trading now?

BBIO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does BBIO sit relative to its 52-week high and low?

Over the past 52 weeks, BBIO has traded between a low of $ 52.75 and a high of $ 93.42. At $ 65.39, the stock is positioned 31.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is BridgeBio Pharma, Inc. in?

BridgeBio Pharma, Inc. (BBIO) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is BridgeBio Pharma, Inc.'s market capitalisation and where is it listed?

BridgeBio Pharma, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 12.78B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is BBIO valued in terms of P/E ratio and EPS?

BBIO trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -3.54. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does BridgeBio Pharma, Inc. pay a dividend?

BridgeBio Pharma, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.